Testing effectiveness (Phase 2)Looking for participantsNCT07398508
What this trial is testing
Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease.
Who this might be right for
Menkes Disease
Stephen G. Kaler 6